DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Yordanova A, Becker A, Eppard E. et al.
The impact of repeated cycles of radioligand therapy using [(177)Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.
Eur J Nucl Med Mol Imaging 2017;
44: 1473-1479 . doi:10.1007/s00259-017-3681-9
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.